Jiangsu Nhwa Pharmaceutical Co Ltd SZSE:002262:
SAYS 2025 NET PROFIT DOWN 7.5% Y/Y
Jiangsu Nhwa Pharmaceutical Says 2025 Net Profit Down 7.5%
Earlier from Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
- Jiangsu Nhwa Pharmaceutical: Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectively
- Jiangsu Nhwa Pharmaceutical Q3 Net Profit Up 3.7% Y/Y
- Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth
- Jiangsu Nhwa Pharmaceutical: Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returns